Chan Kai Chun, Yang Timothy Xianyi, Khu Kin Fai, So Ching Vincent
Department of Anaesthesiology and Operating Theatre Services, Queen Elizabeth Hospital, Kowloon, HKG.
Department of Anaesthesiology, Princess Margaret Hospital, Kowloon, HKG.
Cureus. 2023 May 5;15(5):e38611. doi: 10.7759/cureus.38611. eCollection 2023 May.
High-flow nasal cannula (HFNC) is an emerging option for maintaining oxygenation in patients undergoing laryngeal surgery, as an alternative to traditional tracheal ventilation and jet ventilation (JV). However, the data on its safety and efficacy is sparse. This study aims to aggregate the current data and compares the use of HFNC with tracheal intubation and jet ventilation in adult patients undergoing laryngeal surgery. We searched PubMed, MEDLINE (Medical Literature Analysis and Retrieval System Online, or MEDLARS Online), Embase (Excerpta Medica Database), Google Scholar, Cochrane Library, and Web of Science. Both observational studies and prospective comparative studies were included. Risk of bias was appraised with the Cochrane Collaboration Risk of Bias in Non-Randomized Studies - of Interventions (ROBINS-I) or RoB2 tools and the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for case series. Data were extracted and tabulated as a systematic review. Summary statistics were performed. Meta-analyses and trial sequential analyses of the comparative studies were performed. Forty-three studies (14 HFNC, 22 JV, and seven comparative studies) with 8064 patients were included. In the meta-analysis of comparative studies, the duration of surgery was significantly reduced in the THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) group, but the number of desaturations, need for rescue intervention, and peak end-tidal CO were significantly increased compared to the conventional ventilation group. The evidence was of moderate certainty and there was no evidence of publication bias. In conclusion, HFNC may be as effective as tracheal intubation in oxygenation during laryngeal surgery in selected adult patients and reduces the duration of surgery but conventional ventilation with tracheal intubation may be safer. The safety of JV was comparable to HFNC.
高流量鼻导管(HFNC)是一种用于在接受喉部手术的患者中维持氧合的新兴选择,可作为传统气管通气和喷射通气(JV)的替代方法。然而,关于其安全性和有效性的数据较少。本研究旨在汇总当前数据,并比较HFNC与气管插管和喷射通气在接受喉部手术的成年患者中的应用。我们检索了PubMed、MEDLINE(医学文献分析与检索系统在线,或医学文献联机检索系统)、Embase(医学文摘数据库)、谷歌学术、Cochrane图书馆和科学网。纳入了观察性研究和前瞻性比较研究。使用Cochrane协作组织的非随机干预研究中的偏倚风险(ROBINS-I)或RoB2工具以及乔安娜·布里格斯研究所(JBI)病例系列关键评估清单对偏倚风险进行评估。数据被提取并制成表格作为系统评价。进行了汇总统计。对比较研究进行了荟萃分析和试验序贯分析。纳入了43项研究(14项HFNC、22项JV和7项比较研究),共8064例患者。在比较研究的荟萃分析中,THRIVE(经鼻湿化快速充气通气交换)组的手术时间显著缩短,但与传统通气组相比,血氧饱和度下降次数、抢救干预需求和呼气末二氧化碳峰值显著增加。证据的确定性为中等,且没有发表偏倚的证据。总之,在选定的成年患者中,HFNC在喉部手术期间的氧合方面可能与气管插管一样有效,并可缩短手术时间,但气管插管的传统通气可能更安全。JV的安全性与HFNC相当。